Search hospitals > Ohio > Marion
OhioHealth Marion General Hospital
Claim this profileMarion, Ohio 43302
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
134 reported clinical trials
6 medical researchers
Summary
OhioHealth Marion General Hospital is a medical facility located in Marion, Ohio. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Adenocarcinoma and other specialties. OhioHealth Marion General Hospital is involved with conducting 134 clinical trials across 328 conditions. There are 6 research doctors associated with this hospital, such as Timothy D. Moore, Aine E. Clements, Anitha S. Nallari, and Chaoyang Li.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Timothy D. MooreThe Mark H Zangmeister Center4 years of reported clinical research
Expert in Cancer
Expert in Lung Cancer
126 reported clinical trials
208 drugs studied
Aine E. ClementsOhioHealth Mansfield Hospital7 years of reported clinical research
Studies Ovarian Cancer
Studies Cancer
6 reported clinical trials
31 drugs studied
Anitha S. NallariColumbus Oncology and Hematology Associates9 years of reported clinical research
Studies Cancer
Studies Renal Cell Carcinoma
3 reported clinical trials
6 drugs studied
Chaoyang LiDelaware Health Center-Grady Cancer Center8 years of reported clinical research
Studies Skin Cancer
Studies Melanoma
2 reported clinical trials
8 drugs studied
Clinical Trials running at OhioHealth Marion General Hospital
Breast Cancer
Lung Cancer
Cancer
Bladder Carcinoma
Non-Small Cell Lung Cancer
Melanoma
Cutaneous Melanoma
Ovarian Cancer
Bladder Cancer
Multiple Myeloma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting1 award Phase 217 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at OhioHealth Marion General Hospital?
OhioHealth Marion General Hospital is a medical facility located in Marion, Ohio. This center is recognized for care of Cancer, Lung Cancer, Breast Cancer, Recurrence, Adenocarcinoma and other specialties. OhioHealth Marion General Hospital is involved with conducting 134 clinical trials across 328 conditions. There are 6 research doctors associated with this hospital, such as Timothy D. Moore, Aine E. Clements, Anitha S. Nallari, and Chaoyang Li.